Helping patients achieve their functional goals using innovative scientific evidence for non-surgical interventions.
Avoid invasive surgery with Regenexx® — non-surgical treatment options for those suffering from pain related to osteoarthritis, joint injuries, spine pain, overuse conditions, and common sports injuries.
Dr. Jamie Lewis is a Board Certified physician in both Physical Medicine and Rehabilitation with a subspecialty in Pain Medicine. He treats patients throughout the Pacific Northwest…Read more
Dr. Ghassan Nemri is a graduate of Minsk State Medical University. He completed an Anesthesiology residency program at Cook County Hospital in Chicago, Illinois…Read more
*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
Regenexx® Procedures – The Trusted Alternative to Surgery
Regenexx Physicians represent a very selective, highly-skilled, interventional orthobiologics network that is 100% focused on orthopedic conditions:
- Spine pain and disorders
- Osteoarthritis of joints and spine
- Tendon and ligament tears
- Cartilage damage
- And many more conditions that cause pain.
A Leader in Regenerative Orthopedic Treatment Options for Arthritis, Joint Injuries and Spine Conditions.
Watch this video for an in-depth overview of how Regenexx treatments and research are designed to produce the best possible outcomes for patients with orthopedic conditions, joint injuries, arthritis, or spine pain.Learn more
Regenexx is a world leader in the field of orthopedic regenerative medicine based on scientific publications and is arguably the world’s most advanced platform for in-office interventional orthobiologics.
More than 139,300 highly specific image-guided Regenexx® Procedures have been performed since Regenexx pioneered the field of interventional orthopedics, using bone marrow concentrate to treat common orthopedic problems in 2005.
The published research on Regenexx procedures accounts for approximately 44% of the world’s research on the use of bone marrow concentrate for orthopedic conditions (cumulative n of patients published & treated with bone marrow concentrate as of 1/1/2019)